These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8427450)

  • 21. Naloxone therapy of human septic shock.
    Bonnet F; Bilaine J; Lhoste F; Mankikian B; Kerdelhue B; Rapin M
    Crit Care Med; 1985 Nov; 13(11):972-5. PubMed ID: 2932301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of digitalis on hemodynamics in acute myocardial infarct. II. Myocardial infarct associated with acute severe insufficiency of the left heart and cardiogenic shock].
    Schüren KP; Ramdohr B; Dissmann W; Buschmann HJ; Schröder R
    Klin Wochenschr; 1970 May; 48(10):591-7. PubMed ID: 5517327
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of Ulinastatin on circulatory function restoration in patients with acute myocardial infarction in cardiogenic shock].
    Wang Y; Ma PL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Sep; 21(9):562-3. PubMed ID: 19751570
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cardiogenic shock and severe hypotension in acute myocardial infarct treated with glucagon. Preliminary experience from a coronary unit].
    Amtorp O; Christiansen I; Wennevold A
    Ugeskr Laeger; 1971 May; 133(18):867-70. PubMed ID: 5577747
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of prenalterol in cardiogenic shock occurring in acute myocardial infarct].
    Coma-Canella I
    Ter Arkh; 1982; 54(11):104-5. PubMed ID: 6130619
    [No Abstract]   [Full Text] [Related]  

  • 26. Tilarginine in patients with acute myocardial infarction and cardiogenic shock.
    Teerlink T
    JAMA; 2007 Sep; 298(9):971-2; author reply 972-3. PubMed ID: 17785640
    [No Abstract]   [Full Text] [Related]  

  • 27. Opioid peptides in pathological states.
    Slepushkin VD; Zoloev GK; Kun VI
    Z Med Lab Diagn; 1989; 30(5):281-2. PubMed ID: 2528861
    [No Abstract]   [Full Text] [Related]  

  • 28. [Successful use of levosimendan in a patient with cardiogenic shock complicating acute myocardial infarction].
    Mustapha F; Moufida H; Nedia B; Anis L; Iheb L; Habib H
    Tunis Med; 2005 Oct; 83(10):635-7. PubMed ID: 16370217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increases in plasma beta-endorphin concentrations during exercise do not contribute to increases in heart rate following autonomic blockade in man.
    Shen A; Chin J; Fullerton M; Jennings G; Dart A
    Br J Clin Pharmacol; 1992 Jan; 33(1):89-92. PubMed ID: 1540495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tilarginine in patients with acute myocardial infarction and cardiogenic shock.
    Kielstein JT; Sydow K; Thum T
    JAMA; 2007 Sep; 298(9):971; author reply 972-3. PubMed ID: 17785641
    [No Abstract]   [Full Text] [Related]  

  • 31. Naloxone in shock.
    Lancet; 1980 Dec 20-27; 2(8208-8209):1360. PubMed ID: 6109169
    [No Abstract]   [Full Text] [Related]  

  • 32. Prospective evaluation of early abciximab and primary percutaneous intervention for patients with ST elevation myocardial infarction complicated by cardiogenic shock: results of the REO-SHOCK trial.
    Zeymer U; Tebbe U; Weber M; Vohringer HF; Jaksch R; Bischoff KO; Toepel W; Marsalek P; Horn S; Neuhaus KL;
    J Invasive Cardiol; 2003 Jul; 15(7):385-9. PubMed ID: 12840235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of thrombolysis in the treatment of cardiogenic shock following myocardial infarct].
    Reynard CA; Urban P
    Schweiz Med Wochenschr; 1992 Jul; 122(30):1123-8. PubMed ID: 1496339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma beta-endorphin and the effect of naloxone on hemodynamic changes during experimental acute pancreatitis in dogs.
    Satake K; Hiura A; Nishiwaki H; Ha SS; Chung YS; Umeyama K
    Surg Gynecol Obstet; 1989 May; 168(5):402-6. PubMed ID: 2540537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucagon in the treatment of cardiogenic shock following acute myocardial infarction.
    O'Brien ET; Howarth E; Singh SP
    J Ir Med Assoc; 1973 Aug; 66(15):415-7. PubMed ID: 4727938
    [No Abstract]   [Full Text] [Related]  

  • 36. [Beta-endorphin and cortisol in acute myocardial infarct].
    Markuljak I; Hendrich F
    Vnitr Lek; 1986 Apr; 32(4):337-42. PubMed ID: 2941917
    [No Abstract]   [Full Text] [Related]  

  • 37. L-carnitine in cardiogenic shock therapy: pharmacodynamic aspects and clinical data.
    Corbucci GG; Loche F
    Int J Clin Pharmacol Res; 1993; 13(2):87-91. PubMed ID: 8354594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppressed MMP-9 Activity in Myocardial Infarction-Related Cardiogenic Shock Implies Diminished Rage Degradation.
    Selejan SR; Hewera L; Hohl M; Kazakov A; Ewen S; Kindermann I; Böhm M; Link A
    Shock; 2017 Jul; 48(1):18-28. PubMed ID: 28608784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dynamics of interleukin 6 levels in the patients with cardiogenic and septic shock and in a control group of patients with uncomplicated AMI].
    Pařenica J; Maláska J; Jarkovský J; Helánová K; Jabandžiev P; Michálek J; Veselková Z; Littnerová S; Kubková L; Gál R; Sevčík P; Goldbergová MP; Litzman J; Čermáková Z; Špinar J
    Vnitr Lek; 2014 Feb; 60(2):114-22. PubMed ID: 24754415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial.
    ; Alexander JH; Reynolds HR; Stebbins AL; Dzavik V; Harrington RA; Van de Werf F; Hochman JS
    JAMA; 2007 Apr; 297(15):1657-66. PubMed ID: 17387132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.